Department of General Surgery, Clínica Universidad de Navarra, School of Medicine, University of Navarra, Pamplona, Spain; Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Spain.
Department of General Surgery, Clínica Universidad de Navarra, School of Medicine, University of Navarra, Pamplona, Spain.
Int J Surg. 2018 Apr;52:303-308. doi: 10.1016/j.ijsu.2018.03.001. Epub 2018 Mar 9.
The objective is to analyze the impact of severe postoperative complications in patients undergoing curative surgery for colon cancer.
From a prospective database, we identified patients with stage I-III disease (AJCC) who underwent surgery between 2000 and 2014. Patients were selected with major complications (IIIb on the Clavien-Dindo classification) and with no major complications. Variables were analyzed in both groups. Local, peritoneal and distant recurrence together with overall survival and disease-free survival were analyzed.
Of a total of 950 patients, 51 (5.3%) experienced major complications. Operative mortality was 2.6%. Age, ASA grade, urgent surgery, pre-operative hemoglobin, right-sided location, operative time, transfusion, conversion to open surgery, were all associated with major complications (all P < 0.05). With a median follow-up of 84.8 and 40 months in both groups, there was greater incidence of local recurrences in patients experiencing complications (2.4% vs 7.8%; P = 0.03 OR 3.39, 95% CI 1.12-10.24), being more marked in stage III patients (4.2% vs 21%; P = 0.005, OR 6.13 95% CI 1.74-21.56). In the stage III group, peritoneal recurrence was significantly greater in patients with complications (13.6% vs 31.6%; P = 0.04 OR 2.92 95% CI 1.04-8.18). Patients with major complications had a significantly lower overall survival (P = 0.024) than patients with no complications both at 5 years (78.9% vs 68.8%) and 10 years (74.6% vs 32.1%). The same trend was observed for disease-free survival (71.6% vs 48.3% and 69.8% vs 32.2%; P = 0.013).
The development of major complications following colectomy for colon cancer has a negative impact on long-term oncologic outcomes, especially in stage III disease.
分析结肠癌根治性手术后严重术后并发症对患者的影响。
我们从一个前瞻性数据库中确定了 2000 年至 2014 年间接受手术的 I-III 期(AJCC)疾病患者。选择有严重并发症(Clavien-Dindo 分级 IIIb)和无严重并发症的患者。对两组患者的变量进行分析。局部、腹膜和远处复发以及总生存和无病生存情况。
总共 950 例患者中,51 例(5.3%)发生严重并发症。手术死亡率为 2.6%。年龄、ASA 分级、急诊手术、术前血红蛋白、右侧位置、手术时间、输血、中转开腹与严重并发症均相关(均 P<0.05)。两组的中位随访时间分别为 84.8 个月和 40 个月,并发症患者局部复发发生率更高(2.4% vs 7.8%;P=0.03,OR 3.39,95%CI 1.12-10.24),III 期患者更为显著(4.2% vs 21%;P=0.005,OR 6.13,95%CI 1.74-21.56)。在 III 期患者中,并发症患者腹膜复发显著更高(13.6% vs 31.6%;P=0.04,OR 2.92,95%CI 1.04-8.18)。严重并发症患者的总生存显著低于无并发症患者(P=0.024),5 年时为 78.9% vs 68.8%,10 年时为 74.6% vs 32.1%。无病生存也呈现出相同的趋势(71.6% vs 48.3%和 69.8% vs 32.2%;P=0.013)。
结肠癌根治性手术后严重并发症的发生对长期肿瘤学结果有负面影响,尤其是在 III 期疾病患者中。